Evidence map›Paper›PMID 34709525›Full record

ArticleMolecular diversity2022

Analysis of the uncharted, druglike property space by self-organizing maps.

Gergely Takács, Márk Sándor, Zoltán Szalai, Róbert Kiss, György T Balogh

Abstract read
In one paragraph

Article in Molecular diversity, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gergely TakácsDepartment of Chemical and Environmental Process Engineering, Budapest University of Technology and Economics, Műegyetem rakpart 3, Budapest, 1111, Hungary.
Márk SándorMcule.com Kft, Bartók Béla út 105-113, Budapest, 1115, Hungary.
Zoltán SzalaiMcule.com Kft, Bartók Béla út 105-113, Budapest, 1115, Hungary.
Róbert KissMcule.com Kft, Bartók Béla út 105-113, Budapest, 1115, Hungary. rkiss@mcule.com.
György T BaloghDepartment of Chemical and Environmental Process Engineering, Budapest University of Technology and Economics, Műegyetem rakpart 3, Budapest, 1111, Hungary. balogh.gyorgy@vbk.bme.hu.ORCID http://orcid.org/0000-0003-3347-1880

Funding

H2020 European Research Council 777828Nemzeti Kutatási, Fejlesztési és Innovaciós Alap 1010984
6 · The paper itself

Abstract

Physicochemical properties are fundamental to predict the pharmacokinetic and pharmacodynamic behavior of drug candidates. Easily calculated descriptors such as molecular weight and logP have been found to correlate with the success rate of clinical trials. These properties have been previously shown to highlight a sweet-spot in the chemical space associated with favorable pharmacokinetics, which is superior against other regions during hit identification and optimization. In this study, we applied self-organizing maps (SOMs) trained on sixteen calculated properties of a subset of known drugs for the analysis of commercially available compound databases, as well as public biological and chemical databases frequently used for drug discovery. Interestingly, several regions of the property space have been identified that are highly overrepresented by commercially available chemical libraries, while we found almost completely unoccupied regions of the maps (commercially neglected chemical space resembling the properties of known drugs). Moreover, these underrepresented portions of the chemical space are compatible with most rigorous property filters applied by the pharma industry in medicinal chemistry optimization programs. Our results suggest that SOMs may be directly utilized in the strategy of library design for drug discovery to sample previously unexplored parts of the chemical space to aim at yet-undruggable targets.

Indexed as

Drug DiscoverySmall Molecule LibrariesAlgorithmsDatabases, ChemicalDatabases, FactualSmall Molecule LibrariesChemical spaceCompound librariesDruglikenessPhysicochemical propertiesSelf-organizing maps

Identifiers

PMID34709525
PMCPMC9532340

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.